O'Hanesian, M.A.( M.A. O'Hanesian)
patient angioplasty occlusion restenosi group follow-up artery diameter stenosi study group 1 patients subtotal angiography follow-up angiography angioplasty procedure event lumen diameter frequency lumen month trial group 2 patients infarction procedure reocclusion percutaneous transluminal lumen diameter stenosis cilazapril transluminal analysis subtotal stenoses angiographic result marcator reference figure lesion percutaneou benefit heart 6 months subtotal stenosis disease duration definition angiogram surgery angina stenose 139 patients distribution circulation reference diameter table vessel cardiol outcome distribution curve difference follow-up period balloon angioplasty period berger end points study patients occlusion balloon reocclusion rate enzyme multicenter postangioplasty heart failure artery occlusion marcator study group 1 6- month follow-upperiod january success success rate holmes dr jr treatment
1 Most Recent Publications
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
Berger, P.B. Holmes Jr, D.R. Ohman, E.M. O'Hanesian, M.A. Murphy, J.G. Schwartz, R.S. Serruys, P.W.J.C. Faxon, D.P.